| |
Abstract |
- In 2010, an estimated 11,406 emergency department (ED) visits involved a synthetic cannabinoid product, sometimes referred to as “synthetic marijuana” and commonly known by street names such as “Spice” or “K2” – Three fourths of these ED visits involved patients aged 12 to 29 (75 percent), of which 78 percent were male – The majority (76 percent) of these ED visits did not receive follow-up care upon discharge from the ED |
|
